Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | IL-6 | 100 | ug/mL | 3 | IL-8 | 455.0 | 80 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 284.0 | 79 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 250.0 | 71 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 805.0 | 84 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 692.0 | 86 | |
| RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 304.5 | 70 | |
| RA2159 | Sigma A6730 | 3.0 | uM | 3 | IL-8 | 699.0 | 75 | ||||
| N2586 | IL-6 | 100 | ug/mL | 3 | IL-8 | 1066.0 | 92 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 859.0 | 91 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 798.0 | 73 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 958.0 | 87 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 1261.0 | 73 | |
| N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-8 | 682.0 | 76 | |
| N2586 | Sigma A6730 | 3.0 | uM | 3 | IL-8 | 1172.0 | 71 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 9955.5 | 82 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 10893.5 | 76 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 7248.5 | 72 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 11381.5 | 80 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 12497.0 | 75 | |
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 996.0 | 74 | |
| RA2159 | PI103 | 0.1 | uM | 3 | IL-8 | 725.5 | 54 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 9271.0 | 80 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 9169.5 | 62 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 8512.0 | 71 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 10862.0 | 73 |